Stay updated on HexaBody-DR5/DR5 Safety Clinical Trial
Sign up to get notified when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.

Latest updates to the HexaBody-DR5/DR5 Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedWebsite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedGastric cancer was added to the study's conditions. The page revision notes show an update to v3.4.2 and the removal of the prior funding-status notice (v3.4.1).SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a government funding lapse notice and NIH Clinical Center status information (cc.nih.gov and opm.gov), and updated the page revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedGlossary functionality is now visible on the page, enabling quick access to defined terms. The footer and labeling have been updated to reflect the latest QC status and compliance notes, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision tag 'v3.4.0'.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision: v3.3.4 updated. The Study Details page content and layout appear unchanged.SummaryDifference0.1%

Stay in the know with updates to HexaBody-DR5/DR5 Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HexaBody-DR5/DR5 Safety Clinical Trial page.